Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
LimFlow SA is a venture-backed medical device company.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Longeviti develops and commercializes implantable neurosurgical devices.
Pillar Biosciences specializes in sequencing technology platform and proprietary data analysis toolkit.
OrganOx is a medical technology company.
Q'Apel Medical designs access device technology for neurovascular interventions and unmet clinical needs.
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
Belite Bio is a clinical stage biopharmaceutical drug development company.
Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.
Quoin Pharmaceuticals is into developing products which address major unmet medical needs.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Field Trip Health is providing simple, evidence-based therapies for healing and heightening engagement with the world.
Soleus Capital has invested in 34 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Soleus Capital's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, Celcuity received $500.0M in a Post Ipo Debt round. Soleus Capital's total known invested capital is $2.8B.
Soleus Capital's average investment size is $81.2M across its portfolio of 34 companies.
Recent Soleus Capital portfolio additions include Satellos Bioscience, DarioHealth, Septerna, CervoMed, Orchestra BioMed. These companies were founded in 2020 or later.